
Artificial intelligence (AI) has become the most transformative development in radiology since digital imaging, with deep learning algorithms demonstrating validated—and in controlled settings superior—performance across pulmonary nodule detection, breast cancer screening, tuberculosis (TB) triage, acute stroke identification, and glioma segmentation. Over 950 AI/machine learning–enabled medical devices have received clearance from the U.S. Food and Drug Administration as of 2024, ∼75% within radiology, yet a consequential knowledge gap persists: fewer than 30% of practising radiologists can critically evaluate an AI study and fewer than 20% have received formal AI training. This review addresses that gap by providing a clinically accessible account of core AI concepts, major neural network architectures—including convolutional neural networks, U-Net, generative adversarial networks, vision transformers, and foundation models—the complete model development and validation workflow, and validated clinical applications across all major imaging modalities. We give dedicated attention to the Indian context, where an acute radiologist deficit of 1:50,000 against the World Health Organization-recommended ratio of 1:10,000, a 26% share of the global TB burden, and heterogeneous imaging infrastructure make AI both urgently necessary and uniquely demanding of local validation; we discuss the Ayushman Bharat Digital Mission, federated learning, and the domestic ecosystem of Qure.ai, Niramai, and Sigtuple as structural enablers, as well as algorithmic bias, explainability, and regulatory frameworks. We conclude that AI literacy is no longer optional: the radiologist's role is not threatened by AI but transformed by it—from film reader to AI-augmented clinical imaging physician capable of extending world-class diagnostic care to underserved populations across India and globally.
Artificial intelligence is now embedded in radiology workflows across detection, triage, quantification, and reporting. Yet, most clinicians deploy these tools without a working understanding of how their outputs are generated or where they reliably fail. Unlike conventional rule-based clinical workflows, modern imaging AI systems generate probabilistic outputs whose reliability depends on training data, task definition, and deployment context. Radiologists must understand what these systems actually produce, know their predictable failure points, and never allow a confidence score to replace the clinical reasoning that only a trained human can apply. This review provides a clinician-oriented framework for understanding imaging AI by covering core model architectures, task-based applications, workflow integration, and the practical interpretation of algorithmic outputs. This is important because as imaging AI scales across institutions and populations, the radiologist's capacity to interrogate, contextualize, and, where necessary, override algorithmic outputs becomes not just a clinical skill but a professional responsibility.
This article aims to evaluate the diagnostic performance of panoramic radiomorphometric indices in detecting mandibular cortical bone loss in renal osteodystrophy patients as a follow-up investigation to prior research. A retrospective case–control imaging study was conducted in accordance with STROBE guidelines. Panoramic radiographs of 11 patients with renal osteodystrophy (mean age: 30.3 ± 5.5 years) and 33 age- and gender-matched healthy controls (mean age: 30.6 ± 5.5 years) were analyzed. Cortical thickness was measured bilaterally at three standardized mandibular sites: gonion region (gonial index [GI]), mental foramen region (mental index [MI]), and molar region (mandibular molar index [MMI]) using the MicroDicom imaging software. Intra-rater reliability was assessed via intraclass correlation coefficient (ICC). Statistical analysis included Welch's t-tests, Cohen's d effect sizes, and receiver operating characteristic (ROC) analysis. All three panoramic indices demonstrated significant reductions in osteodystrophy patients compared to controls (p < 0.01). The GI showed the most pronounced decrease (mean difference: –1.90 mm, 95% CI: –2.15 to –1.65 mm, Cohen's d = 5.87), exceeding reductions in MI (–2.22 mm, d = 1.28) and MMI (–1.85 mm, d = 1.40). Intra-rater reliability was excellent (ICC = 0.905, 95% CI: 0.792–0.958). ROC analysis for GI showed perfect discrimination (AUC = 1.00), with an optimal cutoff >1.27 mm yielding 100% sensitivity and 100% specificity. No significant correlation was observed between mandibular indices and dialysis duration in this small cohort. Panoramic radiographic indices, particularly the GI, are sensitive markers for mandibular cortical bone loss in renal osteodystrophy. In settings where only panoramic radiographs are available—owing to their low cost and wide availability—these measurements may serve as a practical, noninvasive adjunct for detecting skeletal manifestations of chronic kidney disease–mineral and bone disorder. Prospective validation in larger, multicenter cohorts is required before clinical translation.
The deployment of artificial intelligence (AI) in clinical radiology has expanded rapidly worldwide, yet a persistent “deployment gap” remains between research performance and real-world clinical utility. The deployment gap refers to the erosion of AI performance when a model trained and validated in controlled environments is exposed to heterogeneous imaging hardware, acquisition protocols, patient demographics, and reporting practices of routine clinical work. A high-performing algorithm is a necessary but insufficient condition for a successful clinical tool. This narrative review presents a five-stage framework for the full AI clinical lifecycle: pre-deployment evaluation with data acquisition and ground truth creation, local clinical validation in shadow mode, workflow orchestration and deployment, continuous post-deployment monitoring, and error analysis with closed-loop improvement. It also considers application of this framework in the specific context of regulatory environments and data governance obligations. Central to our approach is the insight that continuous monitoring requires only three data streams: the AI output, the original study with its DICOM metadata, and an independently sourced ground truth. When these three signals are reconciled in near real-time, institutions can detect performance drift quickly, identify the hardware or protocol correlates of failure, and trigger targeted corrective action—such as filtering out-of-specification inputs—while any model update remains the vendor's responsibility under regulated change control, without modifying the locked device on site. We illustrate the framework using a composite case study of pneumothorax detection drift following a hardware upgrade. We conclude with a practical implementation checklist calibrated to the infrastructure realities of Indian and other resource-variable health systems worldwide, and a call for the Indian Radiological and Imaging Association to develop minimum standards for AI post-market surveillance.